Quantification of the expression level of integrin receptor αvβ3 in cell lines and MR imaging with antibody-coated iron oxide particles
Open Access
- 6 September 2006
- journal article
- research article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 56 (4), 711-716
- https://doi.org/10.1002/mrm.21023
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Iron oxide MR contrast agents for molecular and cellular imagingNMR in Biomedicine, 2004
- Molecular magnetic resonance imaging with targeted contrast agentsJournal of Cellular Biochemistry, 2003
- MR molecular imaging of the Her‐2/neu receptor in breast cancer cells using targeted iron oxide nanoparticlesMagnetic Resonance in Medicine, 2003
- Molecular imaging in living subjects: seeing fundamental biological processes in a new lightGenes & Development, 2003
- Molecular ImagingRadiology, 2001
- Vascular Differences Detected by MRI for Metastatic Versus Nonmetastatic Breast and Prostate Cancer XenograftsNeoplasia, 2001
- Magnetic resonance contrast enhancement of neovasculature with ?v?3-targeted nanoparticlesMagnetic Resonance in Medicine, 2000
- Angiogenesis and Tumor MetastasisAnnual Review of Medicine, 1998
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994
- Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: biodistribution and imaging studies.Radiology, 1987